Astrid Jullion

Robust specification of the roughness penalty prior distribution in spatially adaptive Bayesian P-splines models

Astrid Jullion, Philippe Lambert · Computational Statistics & Data Analysis · 2006 · 93 citations · Full text

Computing, Civil Engineering, Spatial Analysis +14

Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53–MDM2 Inhibitor HDM201

Sébastien Jeay, Stéphane Ferretti, Philipp Holzer et al. · Cancer Research · 2018 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17

Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study

Albiruni R. Abdul Razak, Sebastian Bauer, Cristina Suárez et al. · Clinical Cancer Research · 2021 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and pharmacokinetics of olokizumab, an anti‐IL‐6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study

Kosmas Kretsos, Georg Golor, Astrid Jullion et al. · Clinical Pharmacology in Drug Development · 2014 · 41 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies

Sebastian Bauer, George D. Demetri, Ensar Halilovic et al. · British Journal of Cancer · 2021 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17